×

White House Government Agencies

  • *Federal Reserve officials, including Chicago Fed President Charles Evans and his Boston counterpart, Eric Rosengren are scheduled to speak at separate events and may comment on the central bank's interest rate outlook. *While Fed Chair Janet Yellen did not comment on monetary policy at a conference on Tuesday, Vice Chairman Stanley Fischer hinted on CNBC...

  • LONDON, March 29- On the face of it, the first quarter of the year followed the' risk on' script. U.S. stocks surged to new highs, the Federal Reserve raised interest rates, high yield debt rallied yet again and Wall Street volatility slumped to its lowest in a decade. Investors piled into riskier, high-yielding assets at the expense of safe-haven bonds on the view that...

  • LONDON, March 29- On the face of it, the first quarter of the year followed the' risk on' script. U.S. stocks surged to new highs, the Federal Reserve raised interest rates, high yield debt rallied yet again and Wall Street volatility slumped to its lowest in a decade. Investors piled into riskier, high-yielding assets at the expense of safe-haven bonds on the view that...

  • March 28- The U.S. Food and Drug Administration on Tuesday approved Roche Holding AG's multiple sclerosis drug Ocrevus, putting the potential blockbuster drug back on track after a delay caused by regulators' concerns over manufacturing issues. Roche said Ocrevus will be available to people in the United States within two weeks. The drug's entry into the U.S....

  • LONDON, March 29- GlaxoSmithKline shares gained on Wednesday as lack of news about U.S. approval of a generic copy of its blockbuster inhaled lung drug Advair buoyed speculation that a threat to profits might be delayed. The U.S. Food and Drug Administration had been due to decide by March 28 whether to approve the first substitutable generic copy of the two-part...

  • March 28- The U.S. Food and Drug Administration on Tuesday approved Roche Holding AG's multiple sclerosis drug Ocrevus, putting the potential blockbuster drug back on track after a delay caused by regulators' concerns over manufacturing issues. Roche said Ocrevus will be available to people in the United States within two weeks. The most popular MS treatment...

  • March 28- The U.S. Food and Drug Administration on Tuesday approved Roche Holding AG's multiple sclerosis drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing issues. The drug's entry into the U.S. market was delayed by three months when the FDA in late December pushed back its deadline for an...

  • March 28- The U.S. Food and Drug Administration on Tuesday approved Roche Holding AG's multiple sclerosis drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing issues. The injectable drug, known chemically as ocrelizumab becomes the first U.S. approved medicine for primary progressive form of the...

  • LONDON- Bank of England Executive Director, Chris Salmon speaks at Foreign Exchange Industry event in London. FRANKFURT- European Central Bank Executive Board Member Peter Praet delivers speech at the "2017 Harvard Law Europe- US Symposium on International Financial Systems"- 1750 GMT. NEW YORK- Federal Reserve Bank of San Francisco President John Williams...

  • LONDON- Bank of England Executive Director, Chris Salmon speaks at Foreign Exchange Industry event in London. FRANKFURT- European Central Bank Executive Board Member Peter Praet delivers speech at the "2017 Harvard Law Europe- US Symposium on International Financial Systems"- 1750 GMT. NEW YORK- Federal Reserve Bank of San Francisco President John Williams...

  • The White House said earlier Tuesday that President Donald Trump strongly supports the repeal of the rules approved by the Federal Communications Commission in October under then-President Barack Obama. The White House in its statement said internet providers would need to obtain affirmative "opt-in" consent from consumers to use and share certain...

  • "You know our nation can't run on pixie dust and hope, and the last eight years showed that," Interior Secretary Ryan Zinke said before Trump signed the executive order on a stage at the Environmental Protection Agency lined with coal miners. "These initiatives prevent things from getting worse for coal, but they won't help much," said Charles Dayton, vice president...

  • "You know our nation can't run on pixie dust and hope, and the last eight years showed that," Interior Secretary Ryan Zinke said before Trump signed the executive order on a stage at the Environmental Protection Agency lined with coal miners. "These initiatives prevent things from getting worse for coal, but they won't help much," said Charles Dayton, vice president...

  • NEW YORK, March 28- The dollar rose on Tuesday, bouncing from 4- month lows, as a top Federal Reserve official reinforced expectations of more U.S. rate hikes to come while political uncertainties surrounding Britain's exit from the EU pressured European currencies. Fed Vice Chairman Stanley Fischer said two more increases of U.S. overnight interest rates this...

  • March 28- The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's drug for moderate-to-severe atopic dermatitis, a product widely seen as the most important growth driver for the two companies. Wall Street analysts forecast annual sales exceeding $4 billion by 2022 for the biotech drug known chemically as...

  • March 28- The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's drug for moderate-to-severe atopic dermatitis, a product widely seen as the most important future growth driver for the two companies. Wall Street analysts forecast annual sales exceeding $4 billion by 2022 for the biotech drug known...

  • Federal Reserve Chair Janet Yellen said on Tuesday that investments in education and skills training are vital to address persistently high unemployment among lower-income and minority communities. "Education levels have historically lagged in low- and moderate-income communities, particularly communities of color," Yellen said in prepared remarks on...

  • March 28- The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's Dupixent for treatment of moderate to severe atopic dermatitis, a product widely seen as the most important future growth driver for the two companies. The drug will have a list price of $37,000 a year, Sanofi said. Wall Street analysts forecast...

  • *Wall Street shares up as banks gain. NEW YORK, March 28- Stocks recovered on Tuesday as investors chose to look beyond U.S. Advancing shares in Asia and Europe helped boost the MSCI's all-country world equity index, which hit a near-two-week low on Monday.

  • March 28- The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's Dupixent for treatment of moderate to severe atopic dermatitis, a product widely seen as the most important future growth driver for the two companies.